HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
Genentech announces clinical trials testing TNKase (Tenecteplase) with leading anti-thrombotics for treatment of heart attack; Four studies pair clot-buster with varying combinations of adjunctive agents to seek improvements for heart attack patients.
-
M2 Presswire; Mar 15, 2000; 700+ Words
...15 March 2000-GENENTECH: Genentech announces clinical trials testing TNKase...FRANCISCO, Calif. -- Genentech, Inc. (NYSE...of four clinical trials involving nearly...the comprehensive trial plan, commenced...
-
-
Curis Announces Genentech's Initiation of Phase II Clinical Trial in Advanced Ovarian Cancer with Hedgehog Pathway Inhibitor.
-
Business Wire; Dec 8, 2008; 700+ Words
- Trial Tests GDC...collaborator Genentech has initiated a Phase II clinical trial of GDC...its clinical trial of CUDC...collaboration with Genentech, including the risks that Genentech may experience...currently under clinical development...
-
-
Curis Announces Genentech's Initiation of Hedgehog Antagonist Phase II Clinical Trial In Metastatic Colorectal Cancer.
-
Business Wire; May 5, 2008; 700+ Words
...initiated a Phase II clinical trial of GDC-0449, an orally...cancer. As a result, Genentech will make a $3 million...Passeri. "In addition, Genentech previously has announced...additional Phase II clinical trials of GDC-0449 in the...
-
-
Regeneron initiates VEGF Trap intravitreal clinical development program and Genentech announces July 18 webcast discussion of data presented at ASRS.
-
M2 Presswire; Jul 6, 2005; 700+ Words
...Trap intravitreal clinical development program and Genentech announces July 18 webcast...OTC: FNWU). Genentech, Inc. (NYSE...initiation of a clinical program evaluating...eye. The clinical trial is being conducted...
-
-
HopeLink Announces Key Customer Relationship With Genentech Targeted To Increase Awareness of Clinical Trial Information and Accelerate Patient Enrollment Into Trials.
-
PR Newswire; Oct 2, 2001; 700+ Words
...the HopeLink Clinical Trial Service to help...a number of Genentech's oncology trials. Genentech...requirements for Genentech's trials by answering...questions. Genentech will use the HopeLink Clinical Trial Service to inform...
-
-
Curis, Inc. Announces Initiation of Expansion Cohort in Collaborator Genentech's Phase I Clinical Trial of a Systemically Administered Hedgehog Antagonist.
-
Business Wire; Oct 16, 2007; 700+ Words
...today announced that Genentech has initiated an expansion...its ongoing Phase I clinical trial of a systemically administered...million cash payment from Genentech under the parties...Genentech began a Phase I clinical trial in January 2007...
-
-
Genentech Announces Appointment of Sandra J. Horning, M.D., To Senior Vice President, Global Head, Clinical Development Hematology/Oncology.
-
Blood Weekly; Aug 13, 2009; 700+ Words
...of Medicine and joins Genentech after more than 25 years...colleagues designed numerous clinical trials in lymphoma, specifically...important approvals for Genentech and lymphoma patients...including the Journal of Clinical Oncology, Clinical...
-
-
ImmunoGen, Inc. Announces Presentation of First Clinical Data for Genentech's Trastuzumab-MCC-DM1.
-
Business Wire; Dec 15, 2006; 700+ Words
...study that evaluates Genentech's trastuzumab-MCC...is being developed by Genentech and uses ImmunoGen...The compound comprises Genentech's trastuzumab anti...re delighted with the clinical findings with trastuzumab...in an ongoing Phase I trial designed to assess the...
-
-
Seattle Genetics Announces That Its Anti-CD40 Monoclonal Antibody Enters Clinical Development At Genentech.
-
Business Wire; Jan 8, 2002; 700+ Words
...Seattle Genetics. "Genentech has done a superb job...in multiple ongoing clinical trials. The Company also out...organizations including Genentech, Genencor International...risks related to adverse clinical results as our product...
-
-
Curis Announces Phase II Clinical Plan for Hedgehog Antagonist Presented by Collaborator Genentech.
-
Business Wire; Mar 14, 2008; 700+ Words
...in the ongoing Phase I clinical trial of GDC-0449. Curis anticipates that Genentech will present the Phase...scientific conference. Genentech stated that it plans to initiate three Phase II clinical trials of GDC-0449 in 2008...
-
-
Genentech Announces Phase III Investigational Trial Results for HER2 Monoclonal Antibody in Metastatic Breast Cancer.
-
Business Wire; Dec 19, 1997; 700+ Words
...Fighting Breast Cancer Genentech, Inc. (NYSE:GNE...results of Phase III clinical trials of its Herceptin(TM...Levinson, Ph.D., Genentech's president and chief...controlled Phase III trial evaluated the efficacy...chemotherapy did increase the clinical benefit by slowing the...
-
-
Curis Announces Genentech's Expected Initiation of Pivotal Phase II Trial in Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitor.
-
Business Wire; Jan 15, 2009; 700+ Words
...collaborator Genentech has indicated...pivotal Phase II clinical trial of GDC-0449...failures in its clinical trial of CUDC...collaboration with Genentech, including the risks that Genentech may experience...currently under clinical development...
-
-
Curis Announces Genentech's Initiation of Pivotal Phase II Trial of GDC-0449 in Advanced Basal Cell Carcinoma.
-
Business Wire; Feb 12, 2009; 700+ Words
...that its collaborator Genentech treated the first patient in a pivotal Phase II clinical trial of GDC-0449, an orally...BCC). Curis and Genentech had previously disclosed...arm, two-cohort clinical trial. One cohort includes...
-
-
Genentech Announces Creation Of Genenvax To Develop AIDS Vaccine.
-
Business Wire; Feb 20, 1996; 700+ Words
...and prevention, is president of the new, private company. Francis is the former Genentech clinical scientist in charge of Genentech's gp120 clinical trials. Robert Nowinski, Ph.D. is chairman of Genenvax. Dr. Nowinski is a virologist...
-
-
Genentech Announces Senior Appointments in Medical Affairs And Research.
-
Business Wire; Oct 7, 2002; 700+ Words
...Fyfe, vice president, Clinical Hematology/Oncology Fyfe, 50, joined Genentech in 1997 as director of...director in 1999. While at Genentech, Fyfe's responsibilities...included managing the clinical trials that led to the approvals...
-
-
Genentech Announces Positive Results From a Randomized Phase II Study of Pertuzumab in Combination With Gemcitabine for Advanced Ovarian Cancer.
-
PR Newswire; Jan 4, 2007; 700+ Words
...Hal Barron, Genentech senior vice...results of this trial, and will continue...in previous clinical trials of pertuzumab...part of this trial, and are currently...and previous clinical trials of pertuzumab...had suggested clinical activity - including...breast cancers. ...
-
-
Genentech announces positive results from a Phase IV study of Raptiva in patients with moderate-to-severe hand and foot psoriasis.(Product News)(Clinical report)
-
Dermatology Nursing; Apr 1, 2007; 700+ Words
Genentech, Inc. recently announced results from...double blind, placebo-controlled trial to evaluate a biologic agent in the treatment...consistent with previous company-sponsored clinical trials with Raptiva. Serious adverse events...
-
-
Genentech announces product sales and NYSE listing. (New York Stock Exchange)
-
PR Newswire; Jan 11, 1988; 700+ Words
GENENTECH ANNOUNCES PRODUCT SALES AND NYSE...chief executive officer of Genentech Inc. announced that the...Medicaid. Swanson said Genentech is exploring a number...adults will be tested in clinical trials for burn victims. Other...
-
-
Genentech announces phase II trial of experimental anti-CD18 antibody did not meet its primary objectives.
-
M2 Presswire; Jun 19, 2000; 700+ Words
...2000-GENETECH: Genentech announces phase II trial of experimental anti...FRANCISCO, Calif. -- Genentech, Inc. (NYSE: DNA...patient Phase II clinical trial of the company...M.P.H., Genentech's executive vice...
-
-
ImmunoGen, Inc. Announces Clinical Data Reported at ASCO.
-
Business Wire; Jun 3, 2007; 700+ Words
- Genentech Also Announces Decision to...encouraging clinical findings with...tumors. Genentech has now announced...a Phase II trial of huC242...compound." Clinical Findings Reported...attached to Genentech's HER2...
|
|